Des dirigeants du CN prendront la parole lors de conférences à l’intention des investisseurs les 12, 20 et 21 février
06 févr. 2019 11h30 HE
|
Canadian National Railway
MONTRÉAL, 06 févr. 2019 (GLOBE NEWSWIRE) -- Des cadres du CN (TSX : CNR) (NYSE : CNI) prendront la parole lors de trois conférences à l’intention des investisseurs qui ont lieu en...
EVO Payments to Present at the Goldman Sachs Technology & Internet Conference
30 janv. 2019 16h15 HE
|
EVO Payments, Inc.
ATLANTA, Jan. 30, 2019 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO”), a leading global payment technology and services provider, today announced that Kevin M. Hodges, Chief Financial...
Altair to Present at Needham Growth Conference
08 janv. 2019 08h30 HE
|
Altair Engineering Inc.
TROY, Mich., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Altair (NASDAQ:ALTR) Chief Financial Officer Howard Morof will present at the 21st Annual Needham Growth Conference to be held in New York, NY. The...
EVO Payments to Present at Upcoming Conferences
08 nov. 2018 10h00 HE
|
EVO Payments, Inc.
ATLANTA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO”), a leading global provider of payment technology integration and acquiring solutions, today announced that James...
Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference
26 sept. 2018 08h00 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
29 août 2018 08h00 HE
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
BioSyent to Present at Upcoming Investor Conference
24 août 2018 12h00 HE
|
BioSyent Inc.
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at...
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
08 juin 2018 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and...
BioSyent to Present at Upcoming Investor Conferences
25 avr. 2018 11h45 HE
|
BioSyent Inc.
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) is pleased to announce that it will be presenting at the following upcoming investor conferences: May 2, 2018...
Sarepta Therapeutics to Present at Two Upcoming Investor Conferences
27 févr. 2018 08h30 HE
|
Sarepta Therapeutics, Inc.
CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision...